NASDAQ:NDRA - ENDRA Life Sciences News Headlines

$1.61
-0.09 (-5.29 %)
(As of 09/18/2019 06:00 AM ET)
Today's Range
$1.5873
Now: $1.61
$1.70
50-Day Range
$1.33
MA: $1.55
$1.86
52-Week Range
$0.90
Now: $1.61
$5.75
Volume33,672 shs
Average Volume194,483 shs
Market Capitalization$10.67 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

Headlines

ENDRA Life Sciences (NASDAQ NDRA) News Headlines

Source:
DateHeadline
 Analysts Anticipate ENDRA Life Sciences Inc (NASDAQ:NDRA) to Announce -$0.19 EPS Analysts Anticipate ENDRA Life Sciences Inc (NASDAQ:NDRA) to Announce -$0.19 EPS
www.americanbankingnews.com - September 14 at 12:39 AM
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Seville, Spain on September 26-28, 2019ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Seville, Spain on September 26-28, 2019
finance.yahoo.com - September 10 at 10:38 AM
Analyzing Natus Medical (NASDAQ:NTUS) & ENDRA Life Sciences (NASDAQ:NDRA)Analyzing Natus Medical (NASDAQ:NTUS) & ENDRA Life Sciences (NASDAQ:NDRA)
www.americanbankingnews.com - August 31 at 12:21 AM
Short Interest in ENDRA Life Sciences Inc (NASDAQ:NDRA) Expands By 16.8%Short Interest in ENDRA Life Sciences Inc (NASDAQ:NDRA) Expands By 16.8%
www.americanbankingnews.com - August 29 at 2:41 PM
David R. Wells Purchases 10,000 Shares of ENDRA Life Sciences Inc (NASDAQ:NDRA) StockDavid R. Wells Purchases 10,000 Shares of ENDRA Life Sciences Inc (NASDAQ:NDRA) Stock
www.americanbankingnews.com - August 26 at 5:45 PM
ENDRA Life Sciences Reports Second Quarter 2019 Financial & Operational ResultsENDRA Life Sciences Reports Second Quarter 2019 Financial & Operational Results
finance.yahoo.com - August 8 at 4:32 PM
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and WarrantsENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
finance.yahoo.com - July 29 at 8:51 AM
ENDRA Life Sciences to Host Second Quarter 2019 Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. ETENDRA Life Sciences to Host Second Quarter 2019 Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. ET
finance.yahoo.com - July 22 at 11:20 AM
What Kind Of Investor Owns Most Of ENDRA Life Sciences Inc. (NASDAQ:NDRA)?What Kind Of Investor Owns Most Of ENDRA Life Sciences Inc. (NASDAQ:NDRA)?
finance.yahoo.com - July 4 at 4:08 PM
Endra announces new partnership evaluating TAEUS in fally liver diseaseEndra announces new partnership evaluating TAEUS in fally liver disease
seekingalpha.com - July 1 at 4:03 PM
ENDRA Life Sciences and Rocky Vista University College of Osteopathic Medicine Partnering for Clinical Study of Thermo Acoustic Enhanced Ultrasound DeviceENDRA Life Sciences and Rocky Vista University College of Osteopathic Medicine Partnering for Clinical Study of Thermo Acoustic Enhanced Ultrasound Device
finance.yahoo.com - July 1 at 11:03 AM
ENDRA Life Sciences Inc.: ENDRA Life Sciences to Showcase TAEUS Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019)ENDRA Life Sciences Inc.: ENDRA Life Sciences to Showcase TAEUS Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019)
www.finanznachrichten.de - June 25 at 8:20 AM
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019)ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019)
finance.yahoo.com - June 24 at 7:17 PM
ENDRA Life Sciences Appoints Renaud Maloberti as Chief Commercial OfficerENDRA Life Sciences Appoints Renaud Maloberti as Chief Commercial Officer
finance.yahoo.com - June 3 at 11:06 AM
10-Q: ENDRA LIFE SCIENCES INC.10-Q: ENDRA LIFE SCIENCES INC.
www.marketwatch.com - May 15 at 11:16 AM
ENDRA Life Sciences Reports First Quarter 2019 Financial & Operational ResultsENDRA Life Sciences Reports First Quarter 2019 Financial & Operational Results
finance.yahoo.com - May 14 at 4:47 PM
Chiasma: A Risky Investment OpportunityChiasma: A Risky Investment Opportunity
seekingalpha.com - April 26 at 4:15 PM
ENDRA Life Sciences to Host First Quarter 2019 Results Conference Call on Tuesday, May 14, 2019 at 4:30 p.m. ETENDRA Life Sciences to Host First Quarter 2019 Results Conference Call on Tuesday, May 14, 2019 at 4:30 p.m. ET
finance.yahoo.com - April 24 at 11:30 AM
ENDRA Life Sciences Inc.: ENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of TissueENDRA Life Sciences Inc.: ENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of Tissue
www.finanznachrichten.de - April 17 at 10:33 AM
ENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of TissueENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of Tissue
finance.yahoo.com - April 17 at 10:33 AM
ENDRA Life Sciences Inc.: ENDRA Life Sciences Receives ISO 13485 CertificationENDRA Life Sciences Inc.: ENDRA Life Sciences Receives ISO 13485 Certification
www.finanznachrichten.de - April 3 at 11:22 AM
ENDRA Life Sciences Receives ISO 13485 CertificationENDRA Life Sciences Receives ISO 13485 Certification
finance.yahoo.com - April 3 at 11:22 AM
Endra And TAEUS Technology In NAFLD DiagnosisEndra And TAEUS Technology In NAFLD Diagnosis
seekingalpha.com - April 2 at 2:20 PM
Endra down 43% on TAEUS dataEndra down 43% on TAEUS data
seekingalpha.com - March 29 at 12:07 PM
ENDRA Life Sciences Reports Initial Findings on First Human TAEUS Feasibility Study of Liver FatENDRA Life Sciences Reports Initial Findings on First Human TAEUS Feasibility Study of Liver Fat
finance.yahoo.com - March 29 at 12:07 PM
ENDRA Life Sciences Inc.ENDRA Life Sciences Inc.
www.barrons.com - March 19 at 11:58 AM
ENDRA Life Sciences Reports Full Year 2018 Financial & Operational ResultsENDRA Life Sciences Reports Full Year 2018 Financial & Operational Results
finance.yahoo.com - March 11 at 4:26 PM
ENDRA Life Sciences to Host Fourth Quarter and Full Year 2018 Results Conference Call on Monday, March 11, 2019 at 4:30 p.m. ETENDRA Life Sciences to Host Fourth Quarter and Full Year 2018 Results Conference Call on Monday, March 11, 2019 at 4:30 p.m. ET
finance.yahoo.com - February 22 at 9:37 AM
ENDRA Life Sciences Inc.: ENDRA Life Sciences Announces Artificial Intelligence InitiativeENDRA Life Sciences Inc.: ENDRA Life Sciences Announces Artificial Intelligence Initiative
www.finanznachrichten.de - January 22 at 10:55 AM
ENDRA Life Sciences Announces Artificial Intelligence InitiativeENDRA Life Sciences Announces Artificial Intelligence Initiative
finance.yahoo.com - January 22 at 10:55 AM
ENDRA Life Sciences to Present at the 11th Annual LD Micro Main Event on December 5, 2018ENDRA Life Sciences to Present at the 11th Annual LD Micro Main Event on December 5, 2018
finance.yahoo.com - December 3 at 3:37 PM
ENDRA Life Sciences Reports Third Quarter 2018 Financial ResultsENDRA Life Sciences Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 6 at 10:51 AM
My Stock of the Week: ENDRA Life SciencesMy Stock of the Week: ENDRA Life Sciences
finance.yahoo.com - October 29 at 3:33 PM
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at Three Global Liver and Imaging Conferences in November 2018ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at Three Global Liver and Imaging Conferences in November 2018
finance.yahoo.com - October 24 at 10:37 AM
ENDRA Life Sciences to Host Third Quarter 2018 Results Conference Call on Monday, November 5, 2018 at 4:30 p.m. ETENDRA Life Sciences to Host Third Quarter 2018 Results Conference Call on Monday, November 5, 2018 at 4:30 p.m. ET
finance.yahoo.com - October 23 at 10:28 AM
ENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment OptionENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment Option
finance.yahoo.com - October 16 at 10:18 AM
ENDRA Life Sciences Receives Approval to Initiate Human Studies of its TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Receives Approval to Initiate Human Studies of its TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - October 16 at 10:18 AM
The Daily Biotech Pulse: Clinical Hold Lifted Off Crisprs Gene-Edited Therapy, Endra To Offer SharesThe Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares
www.benzinga.com - October 11 at 9:57 AM
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Geneva Switzerland on September 20-22, 2018ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Geneva Switzerland on September 20-22, 2018
finance.yahoo.com - August 29 at 10:55 AM
Endra Life Sciences up 8%Endra Life Sciences up 8%
seekingalpha.com - August 17 at 3:29 PM
ENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue StructuresENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue Structures
finance.yahoo.com - July 31 at 10:46 AM
ENDRA Life Sciences to Host Second Quarter 2018 Results Conference Call on Monday, August 13, 2018 at 4:30 p.m. ETENDRA Life Sciences to Host Second Quarter 2018 Results Conference Call on Monday, August 13, 2018 at 4:30 p.m. ET
finance.yahoo.com - July 25 at 10:10 AM
ENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS TechnologyENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS Technology
finance.yahoo.com - July 12 at 10:15 AM
ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and WarrantsENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants
finance.yahoo.com - July 2 at 2:13 PM
Your Daily Pharma Scoop: Endra Zooms, Biogen And Eisai Present Positive Results, Synergy Moves UpYour Daily Pharma Scoop: Endra Zooms, Biogen And Eisai Present Positive Results, Synergy Moves Up
seekingalpha.com - June 7 at 10:14 AM
ENDRA Life Sciences nabs U.S. patent assessing fat content in tissue, shares up 58.1%ENDRA Life Sciences nabs U.S. patent assessing fat content in tissue, shares up 58.1%
seekingalpha.com - June 5 at 3:27 PM
ENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - June 5 at 10:12 AM
Should You Worry About ENDRA Life Sciences Inc’s (NASDAQ:NDRA) CEO Pay Check?Should You Worry About ENDRA Life Sciences Inc’s (NASDAQ:NDRA) CEO Pay Check?
finance.yahoo.com - May 25 at 10:24 AM
ENDRA Life Sciences (NDRA) CEO Francois Michelon on Q1 2018 Results - Earnings Call TranscriptENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 17 at 10:11 AM
ENDRA Life Sciences Reports First Quarter 2018 Financial ResultsENDRA Life Sciences Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 16 at 10:22 AM
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel